Literature DB >> 10192386

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection.

E Jouanguy1, S Lamhamedi-Cherradi, D Lammas, S E Dorman, M C Fondanèche, S Dupuis, R Döffinger, F Altare, J Girdlestone, J F Emile, H Ducoulombier, D Edgar, J Clarke, V A Oxelius, M Brai, V Novelli, K Heyne, A Fischer, S M Holland, D S Kumararatne, R D Schreiber, J L Casanova.   

Abstract

The immunogenetic basis of severe infections caused by bacille Calmette-Guérin vaccine and environmental mycobacteria in humans remains largely unknown. We describe 18 patients from several generations of 12 unrelated families who were heterozygous for 1 to 5 overlapping IFNGR1 frameshift small deletions and a wild-type IFNGR1 allele. There were 12 independent mutation events at a single mutation site, defining a small deletion hotspot. Neighbouring sequence analysis favours a small deletion model of slipped mispairing events during replication. The mutant alleles encode cell-surface IFNgamma receptors that lack the intra-cytoplasmic domain, which, through a combination of impaired recycling, abrogated signalling and normal binding to IFNgamma exert a dominant-negative effect. We thus report a hotspot for human IFNGR1 small deletions that confer dominant susceptibility to infections caused by poorly virulent mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192386     DOI: 10.1038/7701

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  126 in total

Review 1.  Science, medicine, and the future: susceptibility to infection.

Authors:  D Kwiatkowski
Journal:  BMJ       Date:  2000-10-28

2.  Mycobacterium avium subsp. paratuberculosis inhibits gamma interferon-induced signaling in bovine monocytes: insights into the cellular mechanisms of Johne's disease.

Authors:  Ryan J Arsenault; Yue Li; Kelli Bell; Kimberley Doig; Andrew Potter; Philip J Griebel; Anthony Kusalik; Scott Napper
Journal:  Infect Immun       Date:  2012-06-11       Impact factor: 3.441

3.  The impact of ISGylation during Mycobacterium tuberculosis infection in mice.

Authors:  Jacqueline M Kimmey; Jessica A Campbell; Leslie A Weiss; Kristen J Monte; Deborah J Lenschow; Christina L Stallings
Journal:  Microbes Infect       Date:  2017-01-10       Impact factor: 2.700

4.  Differential response to interferon-gamma therapy in a family with dominant negative partial interferon-gamma receptor1 deficiency.

Authors:  Anita E Smyth; Paul Jackson; David Lammas; M Suhail Asghar; Alistair D Crockard; Jean-Laurent Casanova; Dinakantha S Kumararatne; J David M Edgar
Journal:  Eur J Pediatr       Date:  2005-09-06       Impact factor: 3.183

5.  Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol.

Authors:  Michael E Abrams; Kristen A Johnson; Sofya S Perelman; Li-Shu Zhang; Shreya Endapally; Katrina B Mar; Bonne M Thompson; Jeffrey G McDonald; John W Schoggins; Arun Radhakrishnan; Neal M Alto
Journal:  Nat Microbiol       Date:  2020-04-13       Impact factor: 17.745

6.  Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.

Authors:  Feyza Gunduz; Chaithanya Mallikarjun; Luis A Balart; Srikanta Dash
Journal:  Exp Mol Pathol       Date:  2013-11-08       Impact factor: 3.362

Review 7.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

8.  CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein.

Authors:  Meghan E Pennini; Yi Liu; Jianqi Yang; Colleen M Croniger; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

Review 9.  Nonsense-mediated decay in genetic disease: friend or foe?

Authors:  Jake N Miller; David A Pearce
Journal:  Mutat Res Rev Mutat Res       Date:  2014-05-28       Impact factor: 5.657

10.  Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I.

Authors:  Tjitske de Boer; Jaap T van Dissel; Taco W J Kuijpers; Guus F Rimmelzwaan; Frank P Kroon; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.